We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Snaps Up Mexican Specialty Drugmaker Rimsa for $2.3 Billion
Teva Snaps Up Mexican Specialty Drugmaker Rimsa for $2.3 Billion
Teva is expanding its footprint in emerging markets with the $2.3 billion purchase of Mexico-based Representaciones e Investigaciones Medicas, or Rimsa, a specialty drugmaker with a portfolio of products and patents across Latin America.